Results 211 to 220 of about 6,410,919 (241)

Discovery of Bis-Thiourea Derivatives as Human DNA Topoisomerase IIα Inhibitors with Potent Anticancer Effects. [PDF]

ACS Omega
Sabuakham S, Kitdumrongthum S, Nasoontorn S, Monmai C, Talabnin C, Araki N, Silsirivanit A, Rungrotmongkol T, Chairoungdua A, Pingaew R, Mahalapbutr P.   +10 more
europepmc   +1 more source

Emerging Treatments in Bone Tumors: Lessons Learned from the ESMO Annual Meeting. [PDF]

Biomolecules
Kotapati S, Manoharan M, Palmerini E.
europepmc   +1 more source

Cross-Species Transcriptomic and Network Analysis of Human and Canine Diffuse Large B-Cell Lymphoma Identifies a Conserved Replication-DNA Damage Module for Drug Repurposing. [PDF]

Vet Comp Oncol
Akbari-Ardabili S, Aghazadeh S.
europepmc   +1 more source

The Dual Role of Human UDP-Glucuronosyltransferase-Mediated Metabolism in Tumor Drug Resistance: Mechanisms and Prospects. [PDF]

Int J Mol Sci
Wang Z, Zhong J, Ren C, Shi H, Fang X, Xiao X, Liu X, Cao D, Zeng X.   +8 more
europepmc   +1 more source

A Rationally Engineered Norfloxacin-Phenoxazine Hybrid as a Dual-Function Anticancer Agent: DNA Intercalation Synergizes with Topoisomerase II Inhibition against Murine Breast Tumor. [PDF]

ACS Med Chem Lett
Roy R, Ria T, Das K, Patial V, Das G, Sk UH.   +5 more
europepmc   +1 more source

Antibiotic development and a path to access in India. [PDF]

Nat Commun
Manesh A, Walia K, Saiyed T, Veeraraghavan B, Paterson DL.   +4 more
europepmc   +1 more source

Past present and future of radiosensitization in cervical cancer. [PDF]

Front Oncol
Julian ON, Velarde I, Advani SJ, Mayadev J, Eskander RN.   +4 more
europepmc   +1 more source

Efficacy and safety of liposomal irinotecan plus nimotuzumab in immune checkpoint inhibitor-refractory recurrent or metastatic nasopharyngeal carcinoma: a single-arm, open-label, phase II trial. [PDF]

EClinicalMedicine
He S, Bei WX, Lu N, Zhao ZY, Ye Y, Chen C, Tang L, Liu L, Lv S, Xiang YQ, Wang L.   +10 more
europepmc   +1 more source

FBX-DMEP suppresses hepatocellular carcinoma through tubulin-associated mitotic dysregulation. [PDF]

J Transl Int Med
Liu R, Li H, Zhao W, Zhong J, Tang Y.
europepmc   +1 more source

Antibody-drug conjugate engineering: from design to efficacy and safety. [PDF]

Signal Transduct Target Ther
Ocana A, Espinosa JR, Alonso-Moreno C, Győrffy B, Tong H, Pandiella A.   +5 more
europepmc   +1 more source